G Mignot

1.5k total citations
15 papers, 414 citations indexed

About

G Mignot is a scholar working on Surgery, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, G Mignot has authored 15 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Pharmacology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in G Mignot's work include Pharmacology and Obesity Treatment (3 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers) and Hallucinations in medical conditions (1 paper). G Mignot is often cited by papers focused on Pharmacology and Obesity Treatment (3 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers) and Hallucinations in medical conditions (1 paper). G Mignot collaborates with scholars based in France and Netherlands. G Mignot's co-authors include François Gueyffier, Marc Buyse, Patrice Nony, Jean‐Paul Boissel, Gilles Châtellier, Wei Li, Florent Boutitie, Michel Cucherat, M. Haugh and R M Chichmanian and has published in prestigious journals such as Therapies and PubMed.

In The Last Decade

G Mignot

12 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Mignot France 3 334 108 108 73 38 15 414
F. Cañas Spain 9 323 1.0× 98 0.9× 57 0.5× 50 0.7× 50 1.3× 25 453
Corina Young United Kingdom 9 530 1.6× 102 0.9× 154 1.4× 84 1.2× 41 1.1× 11 630
Patrick T. Donlon United States 13 388 1.2× 150 1.4× 94 0.9× 92 1.3× 32 0.8× 31 569
B. Lachaux France 9 476 1.4× 182 1.7× 227 2.1× 58 0.8× 62 1.6× 30 601
Ralph Aquila United States 10 357 1.1× 111 1.0× 77 0.7× 77 1.1× 41 1.1× 15 446
Ellen M. Weissman United States 12 276 0.8× 82 0.8× 68 0.6× 39 0.5× 43 1.1× 20 506
Kyoko Higashi Japan 7 349 1.0× 145 1.3× 72 0.7× 24 0.3× 81 2.1× 10 535
Eun Kee Chung South Korea 11 347 1.0× 107 1.0× 88 0.8× 80 1.1× 87 2.3× 15 454
M. Bouhassira France 13 262 0.8× 94 0.9× 47 0.4× 148 2.0× 60 1.6× 25 532
Jamie Karagianis Canada 13 379 1.1× 128 1.2× 66 0.6× 51 0.7× 52 1.4× 26 508

Countries citing papers authored by G Mignot

Since Specialization
Citations

This map shows the geographic impact of G Mignot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Mignot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Mignot more than expected).

Fields of papers citing papers by G Mignot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Mignot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Mignot. The network helps show where G Mignot may publish in the future.

Co-authorship network of co-authors of G Mignot

This figure shows the co-authorship network connecting the top 25 collaborators of G Mignot. A scholar is included among the top collaborators of G Mignot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Mignot. G Mignot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Boissel, J. P., Michel Cucherat, Gilles Châtellier, et al.. (2000). [Outline of the problem of indices of therapeutic efficacy. 4. Expression of efficacy when the underlying illness is incurable. Study Group for the Indices of Efficacy].. PubMed. 54(5). 519–23. 1 indexed citations
2.
Boissel, Jean‐Paul, Michel Cucherat, Wei Li, et al.. (2000). [The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use].. PubMed. 54(4). 405–11. 391 indexed citations
3.
Boissel, Jean‐Paul, Marc Buyse, Michel Cucherat, et al.. (1999). [The problem of therapeutic efficacy indices. 2. Description of the indices].. PubMed. 54(3). 309–14. 2 indexed citations
4.
Chichmanian, R M, et al.. (1993). [Tolerance of famotidine. Study of network of sentinel physicians in pharmaco-vigilance].. PubMed. 47(3). 239–43. 1 indexed citations
5.
Mignot, G, et al.. (1991). [Zolpidem and hypnotic hallucinations].. PubMed. 45(5). 439–439. 2 indexed citations
6.
Chichmanian, R M, et al.. (1991). [Hypersensitivity to hypoglycemic sulfonylurea compounds. Are there cross-reactions?].. PubMed. 46(2). 163–7. 4 indexed citations
7.
Mignot, G, et al.. (1991). [Financial analysis of hospitalizations for adverse effects of drugs. The economic role of the Regional Pharmacovigilance Center].. PubMed. 45(5). 387–90. 2 indexed citations
8.
Chichmanian, R M, et al.. (1991). [Drug-induced rhabdomyolysis].. PubMed. 142(8). 587–91. 2 indexed citations
9.
Chichmanian, R M, et al.. (1990). [Acute rhabdomyolysis induced by fenoverine. 2 cases].. PubMed. 141(5). 490–1. 1 indexed citations
10.
Mignot, G, et al.. (1989). [Exifone: 4 cases of hepatitis].. PubMed. 13(4). 428–9. 2 indexed citations
11.
Mignot, G, et al.. (1988). Vers l'analyse coût/bénéfice d'un centre régional de pharmacovigilance.. Therapies. 43(5). 1 indexed citations
12.
Chichmanian, R M, et al.. (1988). [Methodology of a prospective survey of teratogen monitoring conducted by the regional drug monitoring center in Nice].. PubMed. 42(4). 391–2. 2 indexed citations
13.
Bayle, J, et al.. (1987). [Allergic thrombopenia induced by heparin or pentosan polysulfate].. PubMed. 41(5). 339–43. 3 indexed citations
14.
Mignot, G. (1986). [Neuroleptic malignant syndrome].. PubMed. 41(1). 63–7.
15.
Mignot, G, et al.. (1985). [Drug-induced fever. Physiopathology. Imputability criteria].. PubMed. 40(3). 203–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026